⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11136706 | 0.85 | ALDH1A1 (0.35) | — | |
| SCHEMBL386550 | 0.82 | — | — | |
| SCHEMBL386485 | 0.80 | ALDH1A1 (0.39) | — | |
| SCHEMBL1908110 | 0.79 | ALDH1A1 (0.56) | — | |
| SCHEMBL384233 | 0.78 | ALDH1A1 (0.38) | — | |
| SCHEMBL20820006 | 0.78 | ALDH1A1 (0.38) | — | |
| SCHEMBL64765 | 0.75 | — | — | |
| SCHEMBL127065 | 0.73 | — | — | |
| SCHEMBL2591293 | 0.73 | — | — | |
| Methoxymethane SCHEMBL1476203 | 0.73 | ALDH1A1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116854624-A | Process for producing optically active pyrrolidine compound | 田边三菱制药株式会社 | 2023-10-10 | — | — | CN | disclosed |
| US-11746099-B2 | Method for producing optically active pyrrolidine compounds | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-09-05 | — | — | US | disclosed |
| EP-3578545-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUNDS | MITSUBISHI TANABE PHARMA CORP (JP) | 2023-07-26 | — | — | EP | disclosed |
| CN-110234626-B | Process for producing optically active pyrrolidine compound | 田边三菱制药株式会社 | 2023-07-21 | — | — | CN | disclosed |
| US-20230226034-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PHOTODERMATOSIS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| EP-4166139-A1 | PREVENTIVE OR THERAPEUTIC AGENT FOR ACTINIC SKIN DISEASE | Mitsubishi Tanabe Pharma Corporation (JP) | 2023-04-19 | — | — | EP | disclosed |
| CN-115768428-A | Prophylactic or therapeutic agent for photodermatosis | 田边三菱制药株式会社 | 2023-03-07 | — | — | CN | disclosed |
| US-20220119364-A2 | METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUNDS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2022-04-21 | — | — | US | disclosed |
| US-20210300896-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUNDS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2021-09-30 | — | — | US | disclosed |
| CN-112194649-A | Pyrrolidine compounds and their use as melanocortin receptor agonists | 田边三菱制药株式会社 | 2021-01-08 | — | — | CN | disclosed |
| EP-0369335-B1 | 2-Aminodecaline derivatives and their use | BASF AG (DE) | 1994-02-23 | — | — | EP | disclosed |
| US-5051409-A | Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1991-09-24 | — | — | US | disclosed |
| EP-0369335-A2 | 2-Aminodecaline derivatives and their use | BASF Aktiengesellschaft (DE) | 1990-05-23 | — | — | EP | disclosed |
| EP-0030109-B1 | PROCESS FOR PRODUCING ISOPRENE | KURARAY CO., LTD. (JP) | 1983-10-05 | — | — | EP | disclosed |
| US-4381416-A | Process for producing isoprene | KURARAY CO., LTD. (JP) | 1983-04-26 | — | — | US | disclosed |
| EP-0030109-A1 | Process for producing isoprene | KURARAY CO., LTD. (JP) | 1981-06-10 | — | — | EP | disclosed |
| EP-0004335-A2 | Prostacyclin analogs, process and intermediates for their preparation and their use as medicines | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-10-03 | — | — | EP | disclosed |
| US-4026910-A | Oxidation process using nickel peroxide oxidizing agents | HOFFMANN-LA ROCHE INC. (US) | 1977-05-31 | — | — | US | disclosed |
| US-3994936-A | Catalytic rearrangement | HOFFMANN-LA ROCHE INC. (US) | 1976-11-30 | — | — | US | disclosed |
| US-3981896-A | CONVERSION OF ACETYLENIC ALCOHOLS TO ALDEHYDES AND KETONES | HOFFMANN-LA ROCHE INC. (US) | 1976-09-21 | — | — | US | disclosed |